Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5148 single-dose safety and tolerability study in healthy Japanese adults
jRCT2071240071Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial in Clostridioides difficile colitis (CDI) comparing AZD5148 with Placebo (2 arms). Started Oct 2024; status: completed.
02
Drugs
azd5148
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on jRCT2071240071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240071.